Bioequivalence and Bioavailability Forum

Main page Policy Latest Posts Abbreviations

95% upper bound limit as per FDA for fully replicate crossover BE study [RSABE / ABEL]

posted by dshah – India/United Kingdom, 2021-01-05 09:06 (696 d 15:23 ago) – Posting: # 22174
Views: 1,314

Hi Yogeshla!

❝ Suppose 95% UB result is 0.001, is it acceptable to FDA?

The 95% UB would not be acceptable for 0.001.

Regards,
dshah

Complete thread:

95% upper bound limit as per FDA for fully replicate crossover BE study yogeshla 2021-01-05 07:01 [RSABE / ABEL]
- 95% upper bound limit as per FDA for fully replicate crossover BE studydshah 2021-01-05 08:06
  - 0.001 > 0 Helmut 2021-01-05 11:01
    - 0.001 > 0 yogeshla 2021-01-05 12:33

Admin contact
22,426 posts in 4,694 threads, 1,600 registered users;
18 visitors (0 registered, 18 guests [including 5 identified bots]).
Forum time: 00:29 CET (Europe/Vienna)

The rise of biometry in this 20^th century,
like that of geometry in the 3^rd century before Christ,
seems to mark out one of the great ages or critical periods
in the advance of the human understanding. R.A. Fisher

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC

Ing. Helmut Schütz